Research and Markets: Glioblastoma Pipeline Highlights 2014-2015

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/66r92x/glioblastoma) has announced the addition of the "Glioblastoma Pipeline Highlights - 2015" report to their offering.

The latest report Glioblastoma Pipeline Highlights - 2015, provides most up-to-date information on key pipeline molecules in the global Glioblastoma market. It covers emerging therapies for Glioblastoma in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

SUMMARY:

- Glioblastoma Phase 3 Clinical Trial Pipeline Molecules

- Glioblastoma Phase 2 Clinical Trial Pipeline Molecules

- Glioblastoma Phase 1 Clinical Trial Pipeline Molecules

- Glioblastoma Preclinical Research Pipeline Molecules

- Glioblastoma Discovery Stage Pipeline Molecules

- Glioblastoma Pipeline Molecules Short-term Launch Highlights

Key Topics Covered:

1. Glioblastoma Pipeline by Stages

2. Glioblastoma Pipeline by Drug Class

3. Glioblastoma Pipeline by Company

4. Glioblastoma Phase 3 Clinical Trial Insights

5. Glioblastoma Phase 2 Clinical Trial Insights

6. Glioblastoma Phase 1 Clinical Trial Insights

7. Glioblastoma Preclinical Research Insights

8. Glioblastoma Discovery Stage Insights

9. Appendix

10. Research Methodology

For more information visit http://www.researchandmarkets.com/research/66r92x/glioblastoma

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals